AstraZeneca CEO says Covid-19 vaccine may be ready by end of year despite pause in trials

AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.